Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 1.5T | 1.2T | 1.3T | 1.2T |
Cost of revenue | 1.0T | 866.5B | 934.1B | 867.3B |
Gross profit | 431.4B | 377.4B | 384.0B | 353.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 345.1B | 292.1B | 309.5B | 290.5B |
Other operating expenses | -19.9B | -1.2B | -282M | 1.5B |
Operating income | 106.2B | 86.5B | 74.8B | 61.0B |
Non operating interest income | ||||
Income | 6.0B | 5.3B | 4.4B | 9.8B |
Expense | 2.1B | 9.3B | 3.4B | 1.2B |
Other income expense | — | — | — | — |
Pretax income | 116.8B | 89.2B | 82.9B | 76.9B |
Tax provision | 16.3B | 21.1B | 16.2B | 15.3B |
Net income | 100.5B | 68.1B | 66.7B | 61.6B |
Basic EPS | — | 31.4 | 29.7 | 27.4 |
Diluted EPS | — | 31.4 | 29.7 | 27.4 |
Basic average shares | — | 2.1B | 2.1B | 316.1B |
Diluted average shares | — | 2.1B | 2.1B | 316.1B |
EBITDA | 171.3B | 152.3B | 135.1B | 124.0B |
Net income from continuing op. | 100.5B | 68.1B | 66.7B | 61.6B |
Minority interests | -1.7B | -2.3B | -4.3B | -3.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |